ResearcherHebei General HospitalNo recent work listed
Gaifang Liu
Matched on OpenAlex author ID A5040696630.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2022: 1 paper · 2023: 1 paper
Papers 2
- A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature. Last author DOI 10.1097/md.0000000000035167↗
- NPTX1 inhibits pancreatic cancer cell proliferation and migration and enhances chemotherapy sensitivity by targeting RBM10. Co-author DOI 10.3892/ol.2022.13275↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Linping Shi · 1 shared paper, 2022
- Jing Wu · 1 shared paper, 2022
- Ning Zhang · 1 shared paper, 2023
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.